Olmesartan HCT Tablet 5/40/12.5 mg

Adult dose

This medication should be taken once daily, with or without food, along with water. It is recommended to take it at the same time each day (e.g., morning) if possible. The recommended dosages are as follows: - 5/20/12.5mg: Administered to patients whose blood pressure is not adequately controlled with the combination therapy of Amlodipine/Olmesartan Medoxomil 5/20mg. - 5/40/12.5mg: Administered to patients whose blood pressure is not adequately controlled with the combination therapy of Amlodipine/Olmesartan Medoxomil 5/40mg.

Child dose

The safety and efficacy of this medication in pediatric patients under 18 years of age have not been established, thus its use is not recommended.

This medication can cause serious harm to the fetus and newborn during the second and third trimesters of pregnancy, so it should be discontinued immediately upon learning of pregnancy. Individuals with allergies to any ingredients in this medication or similar medications, pregnant or breastfeeding women, those with severe hypotension or severe heart disease, and patients with significantly impaired kidney or liver function should not use this medication. Individuals with low blood volume or reduced salt levels may experience hypotensive symptoms when starting this medication, so careful observation is necessary. Patients with impaired renal function, transplant recipients, or those with renal artery issues should also use this medication cautiously, and kidney function and electrolyte status should be monitored frequently through blood tests. Patients with impaired liver function or liver cirrhosis, as well as those with certain heart valve diseases, should also use this medication carefully. The diuretic component in this medication may cause electrolyte imbalances, so periodic monitoring and management of electrolyte abnormalities such as hypokalemia, hyponatremia, and hypercalcemia are necessary. Since this medication lowers blood pressure, dizziness or lightheadedness may occur, so caution is needed when driving or operating dangerous machinery. The Hydrochlorothiazide component rarely causes severe respiratory side effects such as acute respiratory distress syndrome, so any unusual symptoms should be discussed with a doctor immediately. This medication may interact with other drugs, so it is essential to consult a specialist, especially when taken with lithium, non-steroidal anti-inflammatory drugs, or other antihypertensive medications. Elderly patients or children should use this medication cautiously, and it is not recommended for children as safety and efficacy have not been established. In case of overdose, symptoms such as hypotension, palpitations, and bradycardia may occur, so immediate medical attention should be sought for appropriate treatment. This medication should be stored in a tightly sealed container, away from moisture and heat, and should not be transferred to another container.

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, paleness, severe rash with fever, blistering, skin peeling, pain in mucous membranes of the mouth/eyes, shortness of breath or difficulty breathing, asthma attacks, respiratory abnormalities combined with cough and fever, yellowing of the skin or eyes (jaundice), extreme lethargy, sudden and severe headache, thunderclap headache, seizures, altered consciousness, vision abnormalities, paralysis, urination changes

Mild side effects

• Peripheral edema
• headache
• dizziness
• upper respiratory infection
• nasopharyngitis
• urinary tract infection
• sialadenitis
• leukopenia
• thrombocytopenia
• bone marrow suppression

This medication is sensitive to air and moisture, so it must be stored in a tightly sealed container. The appropriate storage temperature is room temperature between 1 and 30 degrees. Avoid storing it in extremely hot or cold places.

Appearance

Pale yellow round film-coated tablet

Package unit

28 tablets (14 tablets/PTP x 2)/carton